The Metabolism of Neoplastic Tissues: The Relative Rates of Acetate and Pyruvate Utilization by Surviving Tissue Slices of Mouse Tumours by Emmelot, P. & Bosch, L.
344
THE METABOLISM OF NEOPLASTIC TISSUES: THE RELATIVE
RATES OF ACETATE AND PYRUVATE UTILIZATION BY
SURVIVING TISSUE SLICES OF MOUSE TUMOURS.
P. EMMELOT AND L. BOSCH.
From the Department of Biochemistry and the Department of Biology and Endocrinology,
Antoni van Leeutenhoekhuis, the Netherlands Cancer Institute,
Amsterda?n, the Netherlands.
Received for publieation March 23, 1955.
IN the biosynthesis ofboth fatty acids and cholesterol the two-carbon fragment
plays a role of importance. Earlier studies of these reactions in slices of tumour
tissues to which acetate-_-C'4 was added as a substrate did not reveal significant
features in the metabolic rates common to each ofthe tumours belonging to one of
three different groups studied (Emmelot and Bosch, 1955a, 1955b). In this
connection pyruvate was of importance, since this compound might also serve as
a precursor of the two-carbon fragment. In contrast with normal tissue, only
very little information is available regarding the role of pyruvate in the synthetic
processes of neoplastic tissue (Zamecnik et al., 1951; Olson, 1951). The present
communication deals with a comparison between the relative rates of the main
metabolic reaction sequences in which acetate and pyruvate are engaged, using
the three tumour groups studied earlier.
EXPERIMENTAL.
Sodium pyruvate-2-C'4 was purchased from the Radiochemical Centre,
Amersham, England. The radiopyruvate was diluted to the desired activity and
an amount equivalent to the acetate-I-C'4 was used, i.e., 1i875 mg. sodium-acetate
(6.1 x 105 cpm as BaCO3 as an ' infinitely thick " layer on 1 square centimetre
area) and 2-5 mg. sodium pyruvate (2.29 x 105 cpm under identical conditions,
equivalent to 3-435 x 105 cpm expressed as acetate-i-C'4). The counting data
of the proteins following pyruvate incubation were calculated from the observed
counts by multiplying with a factor 178 ( 6 ). All otherdataareexpressedas
mmoles ofacetate incorporated or converted to CO2 per 1 g. offresh tissue. Pooled
slices from one or more tumours were divided in two equal parts of 750 mg. each,
and incubated separately in 3-75 ml. Krebs Ringer phosphate buffer supplemented
with the radioactive substrates respectively. Further details are described in
previous papers (Emmelot and Bosch, 1955a, 1955b).
RESULTS.
The incorporation of equivalent amounts of acetate-i-C'4 and pyruvate-2-C14
into the carbon dioxide, protein-bound amino acids, long-chain fatty acids,ACETATE AND PYRUVATE UTILIZATION BY TUMOURS 345
TABLE I.-The in vitro Incorporation of Tracer from Acetate-I-C14 and Pyruvate-
2_C14 into Respiratory Carbon Dioxide, Proteins, Cholesterol and Long-chain
Fatty Acids by Transplanted Ovarian Tumours of the Granulosa Cell Type.
In each experiment tumour slices from one or more animals were pooled
and 750 mg. slices were incubated with 3-75 ml. Krebs Ringer phosphate
buffer containing either 1-875 mg. acetate-i-C14 or 2-5 mg. pyruvate-2-C14
per flask. The data on C02, cholesterol and fatty acids are expressed per
1 g.of fresh tumour tissue. The counts/min. of the proteins are given
as " infinitely thick layers on 1 square centimetre area.
Fatty
CO. Cholesterol. acids.
mmoles of mmoles of mmoles of
substrate substrate substrate
con- Proteins. incor- incor-
Animal verted. counts! porated. porated.
number. Tumour. Substrate. x 103. min. x 105. x 105.
566 T19957 . acetate-l-C14 1.63 . 217 1-00 . 3-70
566 . pyruvate-2-C4 . 7-57 . 3144 1.33 5-15
567 T19957 acetate-1-C14 247 274 1 58 4*87
567 ,, pyruvate-2-C4 9-32 . 1374 1*91 . 47-0
568 T19957 . acetate-i-C4 140 . 247 0*83 . 4-55
568 . ,, pyruvate-2-C4 . 7v23 1745 1*14 . 21 3
656+657 T 5441 acetate--C"4 . 2- 28 . 418 1 50 10*3
656+657 ,, pyruvate-2-C 4-19 956 1-05 . 17-5
658+660 . T 5441 . acetate-1-C4 . 2-57 411 1-87 7.35
658+660 . . pyruvate-2-C4 . 4 52 . 3050 . 3.33 . 24-1
661 +662 . T 5441 acetate-I-C4 1 60 . 545 1 25 . 10 2
661+662 . ,, . pyruvate-2-C4 10-17 . 4710 . 3-22 . 26 8
TABLE II.-The in vitro Incorporation of Tracerfrom Acetate-I-C'4 and Pyruvate-
2-C14 into Respiratory Carbon Dioxide, Proteins, Cholesterol and Long-chain
Fatty Acids by Transplanted Ovarian Tumours of the Sarcomatoid Type.
For conditions of experiment see Table I.
Fatty
CO,. Cholesterol. acids.
mnoles of mmoles of mmoles of
substrate substrate substrate
con- Proteins. incor- incor-
Animal verted. counts/ porated. porated
number. Tumour. Substrate. x 103. min. x 105. x 105.
664+665 T24202 . acetate-l-C4 . 1-18 . 261 0 95 2-27
664+665 . ,, pyruvate-2-C4 . 8-05 . 2593 . 19-6 11-3
666+667 . . T24202 . acetate-1-C14 097 . 242 . 144-
666+667 . . pyruvate-2-C4 . 6- 21 . 2380 . 14- 2 43 8
668+669 . . T24202 . acetate-I-Cl . 0-20 . 103 . 0 29 . 4e93
668+669 . . ,, . pyruvate-2-C4 . 5 08 . 2037 . 763 . 13e4
768+769 . . T26567 . acetate-1-C14 . 083 . 227 . 3 35 144
768+769 . . ,, . pyruvate-2-C4 . 4-57 . 1660 . 119 4.97
770+766+765 . T26567 . acetate-l-Cl" . 057 . 155 . 2-47 . 1i54
770+766+765 . ,, . pyruvate-2-C4 5059 065 . 19-7 8.77346 P. EMMELOT AND L. BOSCH
and the digitonin precipitable steroid fraction was determined in tumour slices of
four transplanted ovarian tumours, one transplanted and one spontaneous
hepatoma. Two ovarian tumours were of the granulosa cell type and the other
two of the sarcomatoid type.
The results of the experiments are summarized in Tables I, II and III. In all
the tumours studied pyruvate appears to be more readily oxidized via the Krebs
cycle than acetate, since the total amount of C14 present in the carbon dioxide
following incubation with pyruvate-2-C14 always exceeded the total activity
contained in carbon dioxide when the equivalent amount of acetate-i-C14 was
used.
TABLE III.-The in vitro Incorporation of Tracerfrom Acetate-I-C14 and Pyruvate-
2-C14 into Respiratory Carbon Dioxide, Proteins, Cholesterol and Long-chain
Fatty Acids by Transplanted and Spontaneous Hepatomas.
For conditions of experiment see Table I.
Fatty
CO2. Cholesterol. acids.
mmoles of mmoles of mmoles of
substrate substrate substrate
con- Proteins. incor- incor-
Animal verted. Counts/ porated. porated.
number. Tumour. Substrate. x 103. mins. x 105. x 105.
523+524 . . T26473 . acetate-i-C14 1-40 121 6-25 . 29-0
523+524 . . pyruvate-2-C14 3-32 418 4-69 . 6-13
533+529 . T26473 acetate-i-C14 1-40 . 156 6-85 . 26-2
533+529 . ., . pyruvate-2-C'4 . 4-08 . 419 . 6-67 . 797
525 . . T26473 . acetate-i-C'4 0-39 111 3-75 . 11.5
525 . . ,, . pyruvate-2-C'4 . 1-63 444 5-72 . 14-1
4000-4006 spontaneous. acetate-i-C14 . 2-40 385 . 36-1 . 86- 1
hepatoma
4000-4006 Ditto . pyruvate-2-C14 . 4-25 . 624 . 33*3 . 82-0
4000-4006 . ,, acetate-I-C14 2-07 336 44-7 . 1054
4000-4006 ,, . pyruvate-2-C14 2-95 . 915 39-8 . 102-5
The sarcomatoid types oxidize pyruvate to a much greater extent than they
do acetate. The least prominent difference between the two substrates, in this
respect, exists in the case ofthe two hepatomas. The incorporation oftracer from
pyruvate into tumour proteins also exceeds that from acetate in all of the six
tumours investigated. Again in the hepatomas the preference of pyruvate
utilization forproteinsynthesis seemslessmarked than in the other tumours. The
differences which exist between the hepatomas, on one hand, and the remaining
tumours on the other, are most clearly demonstrated by the data representing the
lipogenesis.
In both the transplanted and the spontaneous hepatomas acetate incorporation
into fatty acids equals or even surpasses pyruvate incorporation, whereas the
opposite is true for the other four tumours.
As a whole, radioacetate is slightly superior to radiopyruvate in the extent to
which the C14 of the C2 fragment is incorporated into the hepatoma cholesterol.
Although the absolute rates ofpyruvate and acetate utilization differ significantly,ACETATE AND PYRUVATE UTILIZATION BY TUMOURS
the ratio between pyruvate and acetate incorporation into cholesterol is ap-
proximately constant for both hepatomas.
The two sarcomatoid tumours are characterized by a high preponderance of
pyruvate incorporation over thatofacetate into cholesterol.
DISCUSSION.
The question arises as to what may be the regulatory mechanisms which
govern the direction of flow of the two-carbon fragments to the diverse metabolic
products in the neoplastic tissues and to what extent these mechanisms may be
characteristic for a group of tumours.
Acetate seems to be superior to pyruvate as a carbon source for the formation
of higher fatty acids in liver slices (Bloch, 1952 ; Anker, 1948). This is primarily
because pyruvate, in contrast to acetate, is converted for the greater part to
glycogen and lactic acid. Except for the hepatomas, practically no glycogen
storage occurs in the other tumours and hence the competing enzymes, distracting
pyruvate from this alternative metabolic pathway, are not engaged. The rates
to which acetate-i-C14 or pyruvate-2-C14, which both yield 1-C'4-acetyl-coenzyme
A, are incorporated into the substances isolated in this investigation depends
among other things on the relative effective concentrations of competing enzymes
and coenzymes. The potential concentration of coenzyme A (CoA) was deter-
mined in five ofthe six tumours (Emmelot and Bosch, 1955a, 1955b). The results
showed that the content of this enzyme paralleled roughly the synthetic abilities
of the tumours, although it was demonstrated that, in general, the level of CoA
need not be the rate limiting factor in biosynthesis.
Preliminary experiments seem to indicate that the alternative reaction:
pyruvate -- lactate may play some role, since a greater amount of lactate is
produced by the hepatomas (1.0-1 2 mg. lactic acid per g. wet weight of tumour
slices from 3 mg. pyruvate in 1 hour) under aerobic conditions than by the four
remaining tumours (0.7-0.8 mg. lactic acid).
Another important feature is the energy supply necessary for the initial
activation reaction of acetate to acetyl-CoA, in contrast with the formation of
acetyl-CoA starting from pyruvate which needs no adenosine triphosphate. This
may have its bearing on the metabolic processes in the different tumours. There
is ample evidence from this and the preceding investigation, that the sarcomatoid
ovarian tumours oxidize acetic acid at a lower rate than the other tumours studied,
whereas a pronounced preference of the sarcomatoid tumours forpyruvate utiliza-
tion in all the metabolic reactions was noted.
At the moment there seems no simple answer to the question why the tumours
display such quantitative differences in metabolic behaviour, as expressed by the
preferential utilization of acetate or pyruvate for the synthesis of certain cell
constituents. In Table IV the ratio between the incorporation of tracer from
pyruvate and acetate for the various compounds, isolated from the six tumours,
are given. In considering the data from this table, the three tumour groups may
be listed with increasing ability to utilize pyruvate relative to acetate in the order,
hepatomas, ovarian tumours of the granulosa cell type, and ovarian tumours of
the sarcomatoid type.
Despite individual variations in the ratios ofC14 incorporation and the limited
numrber of tumours studied, it may appear from this that regulatory mechanisms
347348 P. EMMELOT AND L. BOSCH
TABLE IV.-Ratio between the Incorporation of C14 from Pyruvate-2-Cl4 and
Acetate-1-C14 into C02, Protein, Cholesterol and Fatty Acids.
Tumour. C02. Proteins. Cholesterol. Fatty acids.
T24202 . . . . 6- 8 . 9.9 . 21 5.0
6-4 . 9.8 9 9
25 . 20 26 2- 7
T26567 . . . . 5.5 . 7.3 . 3 6 3-5
9-8 . 13-3 . 8-0 5.7
T19957 . . . . 4.6 . 14@t5 1-3 . 1-4
3 8 . 5-0 . 1-2 9 7
5-2 . 7-1 . 1-4 4. 47
T 5441 . . . . 1-8 2. 23 .
- 07 . 1-7
1'8 . 7.4 . 18 . 3.3
6-4 . 8 6 2.6 . 2-6
T26473 . . . 24 . 3.5 . 0 75 . 0 21
2-9 . 2-9 . 0-97 . 0.30
4*2 . 4.0 . 15 . 1-2
Spontaneous hepatoma . 1-8 . 1-6 . 0*92 . 0.95
1-4 . 2-7 . 0.90 . 0-97
are operative which control the rate of flow of the carbon intermediates derived
from pyruvate, with respect to those derived from acetate, in a relatively similar
manner in those tumours which belong to the same group.
It must be emphasized that the tumours chosen in the present investigation-
two in each group-differ significantly in both their origin and growth rate. In
the group of hepatomas, spontaneous and transplanted tumours were studied.
The transplanted hepatomas usually took 2-2-5 months per generation, Tumour
5441 ofthe granulosa cell type 1 month and Tumour 19957 4-5 months. The two
sarcomatoid types, on the other hand have a fast growth-rate (3 weeks). Hence
the biochemical features found are not simply due to the rate of tumour growth
per se.
The scope ofthisworkdoes not permit us to state whether similar biochemical
characteristics can be ascribed to other tumours but it is hoped to study this as
soon as possible.
SUMMARY.
1. Therelative rates ofpyruvate andacetate incorporation into carbon dioxide,
protein-bound amino acids, cholesterol and higherfattyacidswere studied in three
different groups consisting of two tumours each.
2. The ratio between pyruvate and acetate incorporation appeared to furnish
a fair means of evaluating differences in metabolic behaviour and of classifying
the six tumours studied into three groups.
3. The tumours could be listed with an increasing ability to utilize pyruvate
relative to acetate in the order: hepatomas, ovarian tumours of the granulosa
cell type, and ovarian tumours ofthe sarcomatoid type.
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